Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical aminophylline for post-viral hyposmia or anosmia
IRCT20220104053625N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of aminophylline in Olfactory disorder (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Olfactory status and Olfactory capacity. Started Feb 2022; status: completed.
02
Drugs
aminophylline
03
Conditions
Olfactory disorder
Beyond the preview
Go deeper on IRCT20220104053625N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220104053625N1.